TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Top Cited Papers
- 1 October 2004
- Vol. 21 (4) , 491-501
- https://doi.org/10.1016/j.immuni.2004.07.020
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serum interleukin‐6 levels reflect the disease status of colorectal cancerJournal of Surgical Oncology, 2003
- The lineage decisions of helper T cellsNature Reviews Immunology, 2002
- Soluble Interleukin 6 Receptor (sIL-6R) Mediates Colonic Tumor Cell Adherence to the Vascular Endothelium: A Mechanism for Metastatic Initiation?Journal of Surgical Research, 2002
- Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand AvailabilityJournal of Biological Chemistry, 2002
- IL-6 and Its Soluble Receptor Orchestrate a Temporal Switch in the Pattern of Leukocyte Recruitment Seen during Acute InflammationImmunity, 2001
- The soluble interleukin 6 receptor: mechanisms of production and implications in diseaseThe FASEB Journal, 2000
- Roles of STAT3 defined by tissue-specific gene targetingOncogene, 2000
- Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte RecruitmentPublished by Elsevier ,1997
- A bioactive designer cytokine for human hematopoietic progenitor cell expansionNature Biotechnology, 1997
- Promotion of colorectal neoplasia in experimental murine ulcerative colitis.Gut, 1996